Stellar names Tessie Che to board
This article was originally published in Scrip
Executive Summary
Stellar Biotechnologies, which develops keyhole limpet hemocyanin (KLH), an immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets, has named Dr Tessie Che to its board of directors. Dr Che is currently chair of the board of privately held Amaran Biotechnology, based in Taiwan. She also co-founded Optimer Pharmaceuticals in 1998, and served as chief operating officer and senior vice-president of corporate affairs at the company.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.